Search Results 1231-1240 of 11249 for Antifungal Resistance

1. Azacitidine With Or Without Nivolumab Or Midostaurin, Or Decitabine And Cytarabine Alone In Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Or High-Risk Myelodysplastic Syndrome - Mayo Clinic

   ... fungal, or viral infection) that is not controlled (defined as exhibiting ongoing signs/symptoms related to the infection and without improvement despite ...

2. A Study To Evaluate The Safety, Tolerability, And Determine The Optimal Dose For The Expansion Cohorts Of VSV-IFNβ-NIS In Combination With Pembrolizumab In Patients With Refractory Solid Tumors - Mayo Clinic

   0) viral, bacterial, or fungal infection within 2 weeks of registration;. Known seropositivity for or active infection by the human immunodeficiency virus ...

3. Delusional parasitosis - Mayo Clinic

   People who have delusional infestation report the following symptoms: Skin rashes or sores that can cause intense itching. Crawling sensations on and under the ...

4. A Study Of Secukinumab Compared To Ustekinumab For Treatment Of Patients With Plaque Psoriasis - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

5. Evaluating the Effectiveness of Apremilast in the Treatment of Subjects with Canker Sores - Mayo Clinic

   Systemic or opportunistic fungal infection. Known active current or history of recurrent bacterial, viral, fungal, mycobacterial or other infections ...

6. A Study Of Doxorubicin Plus Olaratumab (LY3012207) In Participants With Advanced Or Metastatic Soft Tissue Sarcoma - Mayo Clinic

   The participant has a known active fungal, bacterial, or viral infection including human immunodeficiency virus (HIV) or viral (A, B, or C) hepatitis (screening ...

7. Ribociclib And Letrozole In Treating Patients With Relapsed ER Positive Ovarian, Fallopian Tube, Primary Peritoneal, Or Endometrial Cancer - Mayo Clinic

   Platinum sensitive, platinum resistant and platinum refractory disease are eligible. ... fungal, bacterial or viral infections, etc.). Clinically significant ...

8. A Study Of JNJ-68284528, A Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) In Participants With Multiple Myeloma - Mayo Clinic

   Participation eligibility · Evidence of active viral or bacterial infection requiring systemic antimicrobial therapy, or uncontrolled systemic fungal infection.

9. A Phase 3 Randomized, Placebo-controlled, Double-blind Study Of Niraparib In Combination With Abiraterone Acetate And Prednisone Versus Abiraterone Acetate And Prednisone For Treatment Of Subjects With Metastatic Prostate Cancer - Mayo Clinic

   ... resistant prostate cancer (mCRPC) setting; or AA-P outside of the mCRPC setting. Symptomatic brain metastases. History or current diagnosis of ...

10. An Open-Label Safety And Tolerability Study Of INCB062079 In Subjects With Advanced Hepatocellular Carcinoma And Other Malignancies - Mayo Clinic

    Chronic or current active infectious disease requiring systemic antibiotic, antifungal, or antiviral treatment, except concomitant antiviral systemic therapy ...